| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | CAY10662 |
|---|
| Description | A 1,3 disubstituted urea derivative of 17(R),18(S)-EpETE that is more metabolically robust and reduces the contractility of cardiomyocytes with improved potency (EC50 fold higher than required for the effect on cardiomyocytes, 1-5 μM CAY10662 exerts weak dose-dependent sEH inhibition |
|---|
| Size | 100 μg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | EPA cardiomyocyte contraction cardiovascular disease 17(R)18(S)-EpETE 17(R)18(S)-Epoxyeicosatetraenoic acid CYP450 eicosapentaenoic arrhythmia urea cytochrome P450 epoxygenase sEH CAY-10662 CAY 10662 derivative inhibition inhibits inhibitors |
|---|
| Gene, Accession, CAS # | CAS: 1184844-74-3 |
|---|
| Catalog # | 11042-100 |
|---|
| Price | |
|---|
| Order / More Info | CAY10662 from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|